Loading clinical trials...
Loading clinical trials...
An Exploratory Phase 1/2 Clinical Trial Evaluating ALD518 in Subjects With Glucocorticoid-Refractory Acute Graft vs. Host Disease (GVHD) After Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
Conditions
Interventions
ALD518
ALD518
+1 more
Locations
5
United States
City of Hope
Duarte, California, United States
Loyola Medical Center
Maywood, Illinois, United States
Washington University
St Louis, Missouri, United States
The Ohio State University
Columbus, Ohio, United States
Virginia Commonwealth University
Richmond, Virginia, United States
Start Date
March 1, 2012
Primary Completion Date
March 1, 2013
Completion Date
March 1, 2013
Last Updated
February 17, 2021
NCT02611180
NCT03701698
NCT04645667
NCT02806947
Lead Sponsor
CSL Behring
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions